One of the major risk factors for development of chronic obstructive pulmonary disease (COPD) is cigarette smoke. Extracellular Hsp70 (eHsp70) is increased in sera of COPD patients, and can act as damage-associated molecular pattern (DAMP). In this study, we explored inflammatory parameters (cytokine concentrations, Toll-like receptor (TLR) 2 and 4 and Hsp70 expression, mitogen-activated protein kinases (MAPKs) and nuclear factor B (NF-B) activation, and cytotoxicity) after exposure of bronchial-epithelial NCI-H292 cells to cigarette smoke extract (CSE) alone (2.5 and 15%) and in combinations with recombinant human (rh) Hsp70 (0.3, 1 and 3 g ml −1 ). We applied specific MAPKs, NF-B and Hsp70 inhibitors to elucidate rhHsp70 inflammation-associated responses. CSE alone and combinations of 15% CSE with rhHsp70 stimulated IL-1 , IL-6 and IL-8 release. However, rhHsp70 applied with 2.5% CSE decreased secretion of cytokines indicating antagonistic effects. Individual and combined treatments with 2.5% CSE suppressed TLR2 expression. CSE at 15% induced TLR2 and TLR4 gene expression, whereas rhHsp70 abolished that effect. rhHsp70 and 15% CSE alone reduced, while their combination increased, intracellular Hsp70 mRNA level. CSE alone and in combination with rhHsp70 activated extracellular signal-regulated kinase and p38 MAPKs, while inhibition of MAPKs, NF-B and Hsp70 attenuated IL-6 and IL-8 secretion. CSE at 15% reduced cell viability and induced apoptosis, as shown by MTS and caspases-3/7 assays. CSE at 2.5% alone stimulated lactate dehydrogenase release, but cellular membrane integrity remained intact in co-treatments with rhHsp70. rhHsp70 might modulate the inflammatory response of CSE and could also protect NCI-H292 cells against CSE cytotoxicity. Those effects are implemented via MAPK and NF-B signalling pathways.
INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is one of the leading causes of morbidity and mortality worldwide (Global Initiative for Chronic Obstructive Lung Disease, 2018). The disease is characterized by chronic and progressive airflow limitation and enhanced inflammatory response to different noxious particles, particularly to cigarette smoke, in the lung (Global Initiative for Chronic Obstructive Lung Disease, 2018) . The molecular mechanism that leads to abnormal inflammatory response to smoking in COPD patients is still unclear, but it is assumed that it could be the result of the combined effect of genetic susceptibility and chronic exposure to cigarette smoke (Barnes, 2014; Zuo, Lucas, Fortuna, Chuang, & Best, 2015) . Heat shock protein (Hsp) 70, a molecular chaperone, can be localized intracellularly or extracellularly. Intracellular Hsp70 exerts protective and anti-inflammatory effects, while extracellular Hsp70 (eHsp70) can activate innate immune and inflammatory response, thereby exerting a pro-inflammatory effect (Giuliano, Lahni, Wong, & Wheeler, 2011; Krause et al., 2015) . Pro-inflammatory action of eHsp70 is mediated through activation of Toll-like receptor (TLR) 2 and 4, which leads to the activation of the nuclear factor B (NF-B) signal transduction pathway and mitogen-activated protein kinase (MAPK) pathways and consequently to cytokine production (Asea et al., 2000 (Asea et al., , 2002 Joly, Wettstein, Mignot, Ghiringhelli, & Garrido, 2010; Krause et al. 2015; Vabulas et al. 2002) .
Hsp70 is implicated in the pathogenesis of COPD but its role has not been elucidated in detail. Only a few studies have determined the levels of eHsp70 in COPD patients. A higher level of eHsp70 was found in sera of COPD patients compared to healthy individuals (Hacker et al., 2009 ) as well as in the population of coal mine workers with COPD (Cui et al., 2015) . Furthermore, in vitro studies showed that cigarette smoke extract (CSE) is a potent inducer of Hsp70 protein synthesis in different cell types (Asea et al., 2000 (Asea et al., , 2002 Li, Ning, Matthay, Feghali-Bostwick, & Choi, 2007) , and elevated expression of this chaperone correlated with disease severity in lung epithelial cells of COPD patients (Asea et al., 2002) . On the other hand, expression of Hsp70 was reduced and dependent on the smoking status in leukocytes, lymphocytes, and alveolar macrophages from COPD patients (Cui et al., 2015; Joly et al., 2010; Vabulas et al., 2002) .
The aim of this study was to explore inflammatory effect of CSE alone and in combination with eHsp70 on NCI-H292 cell line. The main hypothesis of our research is that eHsp70 alters CSE-induced response in NCI-H292 cells, leading to more pronounced inflammatory effects.
Therefore, after treatment of NCI-H292 cells with recombinant human (rh) Hsp70, CSE or their combination, we determined concentrations of IL-1 , IL-6 and IL-8, expression of Hsp70, TLR2 and TLR4, as well as NF-B and MAPK activation.
MATERIALS AND METHODS

Cell culture and treatments of cells
NCI-H292 human bronchial epithelial cell line (American Type Culture
Collection, Manassas, VA, USA) was cultured in 75 cm 2 flasks with RPMI 1640 medium, at 37 • C in a humidified 5% CO 2 atmosphere. The medium contained 10% fetal bovine serum, 2 mM L-glutamine, 1 mM pyruvate, and 1% penicillin, streptomycin and amphotericin B. Cells were passaged at 90% confluency and seeded on 12-or 96-well plates.
For determination of cytokines, gene expression, protein activation and expression, and lactate dehydrogenase (LDH), 1 × 10 6 cells were seeded onto 12-well plates, while for 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) and caspases-3/7 assay, 5 × 10 3 and 1 × 10 4 cells were seeded onto 96-well plates, respectively. CSE was prepared using Kentucky Research Cigarettes 3R4F (University of Kentucky, Lexington, KY, USA) in RPMI-1640 medium as previously described (Somborac-Bačura, Popović-Grle, Zovko, & Žanić-Grubišić, 2018) . Concentrations of 2.5 and 15% CSE were selected based on the concentration-dependent effects of CSE (2.5%, 5%, 10%, 15% and 20%) on secretion of IL-1 , IL-6 and IL-8 from NCI-H292 cells after 24 h. 
Measurement of cytokine concentration
Cell-free supernatants were collected after 24 h treatment of the cells with rhHsp70, CSE or their combination, and stored at −80 • C until the analysis of cytokine concentration. The concentrations of IL-1 , IL-6 and IL-8 were determined according to the manufacturer's guidelines using commercially available enzyme-linked immunosorbent assay (ELISA) kits (Human IL-1alpha/IL-1F1 DuoSet ELISA, Human IL1beta/IL-1F2 DuoSet ELISA, Human IL-6 DuoSet ELISA, Human CXCL8/IL-8 DuoSet ELISA, Human TNF-alpha DuoSet ELISA; R&D Systems, Minneapolis, MN, USA).
RNA isolation, reverse transcription and quantitative PCR
RNA was isolated from NCI-H292 cell pellets that remained after removal of the medium for cytokine determination. RNA was isolated by the Trizol/chlorophorm method (Rio, Ares, Hannon, & Nilsen, 2010 ) by using Tri reagent (Thermo Fisher Scientific, Waltham, MA, USA). According to the manufacturer's guidelines, cDNA was synthesized using RevertAid First Strand cDNA Synthesis kit (Thermo Fisher Scientific), and qPCR was performed on the 7300 Real Time PCR System using TaqMan Universal Master Mix and TaqMan Gene Expression Assays (Thermo Fisher Scientific): Hs02621280_s1 for TLR2; Hs00152939_m1 for TLR4; Hs00359163_s1 for HSP70; and reference genes Hs99999907_m1 for 2 -microglobulin (B2M) and Hs99999904_m1 for peptidyl prolyl isomerase A (PPIA).
Determination of protein expression levels
Lysis buffer (50 mM Tris-HCl pH 8.0, 137 mM NaCl, 1% Triton X-100, 10% glycerol, 1 mM sodium orthovanadate), and protease inhibitor (Complete Protease Inhibitor Cocktail Tablets, Roche, Basel, Switzerland) was used for lysis of NCI-H292 cells after 20 min on ice, followed by centrifugation at 15,000 g for 20 min at 4 • C. Protein concentration in the lysate was determined by bicinchoninic acid assay (Smith et al., 1985) . Boiling of the samples for 5 min with 6× Laemmli sample buffer (0.375 M Tris-HCl pH 6.8, 12% w/v SDS, 3% v/v glycerol, 0.2% w/v bromophenol blue, 12% -mercaptoethanol in distilled water) in a 5:1 ratio was used for denaturation. 
Measurement of cytotoxicity
For determination of cytotoxicity of CSE alone and in combination with rhHsp70, we measured metabolic activity of cells by MTS assay, catalytic activity of LDH released into cell supernatants by a spectrophotometric method, and apoptotic caspases activity (caspases-3/7) by a luminometric method.
Viability of cells was determined after 24 h treatment using MTS (Promega, Madison, WI, USA) according to the manufacturer's protocol, followed by measurement on a microplate reader (VICTOR3 1420 Multilabel counter, Perkin Elmer, Waltham, MA, USA).
LDH activity was determined according to the manufacturer's protocol in medium above the cells on a semi-automatic analyser
Trace 30 using LDH test kit (Greiner Diagnostic GmbH, Frickenhausen, Germany).
Caspases-3/7 activity was determined using the luminescent assay kit Caspase-Glo R 3/7 assay (Promega) according to the manufacturer's instructions.
Statistical analysis
All data are presented as the mean ± standard deviation (SD), and were tested by analysis of variance (ANOVA) followed by post hoc testing by the Sidak method using Prism 6.01 software (GraphPad Software Inc., La Jolla, CA, USA).
For assessing combined effects of rhHsp70 with CSE, comparison
of measured values and the calculated (expected) values were used Šegvić Klarić, Medić, Hulina, Žanić Grubišić, & Rumora, 2014) . For the calculation of expected value, the following equations were used:
Student's t-test was used to determine the significance of differences between expected (calculated) and measured values. The level of P < 0.05 was considered statistically significant for all analyses.
RESULTS
Effects of different CSE concentrations on secretion of cytokines
Effects of different CSE concentrations on secretion of IL-1 , IL-1 , IL-6, IL-8 and TNF-were determined after 24 h treatment of NCI-H292 cells with 2.5%, 5%, 10%, 15% and 20% CSE. In all experiments, we expressed concentration of cytokines in non-treated cells as 100%
and in treated cells as percentages of concentration of non-treated cells. Concentrations of IL-1 , IL-6 and IL-8 were significantly higher in cells treated with 2.5%, 5% and 15% CSE. Furthermore, secretion of IL-6 was also higher after treatment with 10% and 20% CSE, and secretion of IL-8 was also higher after treatment with 20% CSE (Figure 1 ). IL-1 and TNF-could not be detected by the ELISA method in any experimental condition and were excluded from the following experiments. Based on the described effects on cytokine secretion, we decided to investigate in more detail the effect of one small dose (2.5%) and one high dose (15%) of CSE.
Inflammatory effects of CSE in combination with Hsp70
To assess the pro-inflammatory effect of CSE, which is one of the main risk factors for COPD, NCI-H292 cells were treated with low (1.59 ± 0.15-fold change), 15% CSE (2.89 ± 0.26-fold change) and combinations of 15% CSE and 0.3 or 1 g ml −1 rhHsp70 (1.66 ± 0.16-and 1.80 ± 0.11-fold change, respectively). To the contrary, expression of TLR2 mRNA was reduced after treatment with 0.3 g ml −1 rhHsp70 (0.76 ± 0.05-fold change) compared to non-treated cells.
Combinations of 15% CSE and rhHsp70 also reduced expression of TLR2 mRNA in comparison with 15% CSE (Figure 3 ). In summary, the increase in the level of mRNA for TLR2 provoked by the treatment with 15% CSE was much less profound when rhHsp70
was also applied, while even stronger CSE-triggered increase in TLR4 mRNA level was completely abolished. In contrast, increase in Hsp70 mRNA levels was observed after treatments with combinations of rhHsp70 and 15% CSE in comparison with both non-treated cells and 15% CSE alone. CSE at 2.5% significantly increased ERK phosphorylation compared to untreated cells after 8 h, and so did its combination with 0.3 or 1 g ml −1 rhHsp70 after 30 min, 2 and 8 h (data not shown).
Activation of MAPK signalling pathways
CSE at 15% alone and in combination with rhHsp70 also activated ERK compared to untreated cells after 8 h of treatment. In addition, 15% CSE and its combination with rhHsp70 activated p38 after 30 min and 2 h. However, treatment with 15% CSE and its combination with 1 g ml −1 rhHsp70 for 8 h resulted in a decrease of p38 activity ( Figure 5 ).
We explored NF-B activation indirectly, through detection of phosphorylation of its inhibitory protein I B . Under the applied treatments, we were not able to detect the presence of p-I B (data not shown).
Mechanism of inflammatory response to rhHsp70
To investigate the role of activation of TLR2 and TLR4 as well 
Cytotoxicity of CSE and its combinations with rhHsp70
NCI-H292 cells were treated with 2.5 or 15% CSE alone, and with combinations of CSE and 0.3, 1 or 3 g ml −1 rhHsp70 for 24 h.
Cytotoxicity was determined using the MTS and LDH assays. For determination of caspase activity, cells were treated with 2.5 or 15% CSE, and its combination with 0.3 or 1 g ml −1 rhHsp70 for 2 and 8 h.
CSE at 2.5% increased NCI-H292 cell viability compared to untreated cells, while the combination of 2.5% CSE and rhHsp70 had no significant effect on the cell viability. In contrast, 15% CSE alone and in combination with rhHsp70, caused a significant reduction in the viability of NCI-H292 cells compared to untreated cells, but calculated interactions between these combinations were not significant ( Figure 7 ).
Compared to non-treated cells, 2.5% CSE increased the release of LDH into the medium. However, that increase was not observed when 2.5% CSE was combined with rhHsp70. Combined effects of 2.5% CSE and all concentrations of rhHsp70 were significantly antagonistic. LDH secretion from cells treated with 15% CSE and its combination with rhHsp70 was similar to LDH released from non-treated cells. However, the calculated interactions were significantly antagonistic (Figure 8 ).
Caspases-3/7 activity was unchanged under short 2 h treatment of cells with 2.5% CSE or its combination with rhHsp70. Reduction of caspases-3/7 activity was observed when 8 h exposure to 2.5% CSE or its combination with 1 g ml −1 was applied. Surprisingly, that effect was used. In comparison to non-treated cells, 15% CSE alone and in combination with rhHsp70 resulted in increased caspases-3/7 activity already after 2 h. After 8 h, only 15% CSE resulted in increased caspases-3/7 activity ( Figure 9 ).
To summarize, 2.5% CSE increased metabolic activity of NCI-H292 cells, but also increased LDH secretion, while 15% CSE and its combination with rhHsp70 decreased the viability of cells. rhHsp70 alone in a broad range of concentrations (0.1-30 g ml −1 ) did not affect cell viability, and even decreased caspases-3/7 activity (unpublished results). Interestingly, when applied together with CSE, rhHsp70 had a protective effect on cell membrane integrity. In addition, 2.5% CSE and its combination with 1 g ml −1 rhHsp70 suppressed caspases-3/7 activation after 8 h treatment, while 15% CSE and its combinations with rhHsp70 caused activation of caspases-3/7 already after 2 h.
DISCUSSION
eHsp70 protein belongs to the damage-associated molecular pattern (DAMP) group and can activate the immune system cells by binding to TLR2 and TLR4 receptors, thus stimulating inflammatory cytokine synthesis through NF-B and MAPK signalling pathways (Ferat-Osorio et al., 2014; Murshid, Theriault, Gong, & Calderwood, 2011) . Elevated concentrations of eHsp70 were measured in the blood of patients with COPD and some other inflammatory diseases (Cui et al., 2015; Hacker et al., 2009; Piccinini & Midwood, 2010) . Furthermore, smoking is one of the major risk factors for COPD development and exposing Caspases-3/7 activity in NCI-H292 cells treated with CSE alone and combinations of CSE with rhHsp70 for 2 (a) and 8 h (b). Data are presented as mean ± SD. Dotted line represents caspases-3/7 activity in non-treated cells set as 100%. *Statistically significant (P < 0.05) vs. non-treated cells; **statistically significant (P < 0.05) vs. CSE alone there are numerous studies of the impact of cigarette smoke on intracellular Hsp70, its interaction with eHsp70 is not well explored.
We hypothesized that eHsp70 in combination with CSE will lead to the more pronounced inflammatory effect of CSE. In our preliminary study, rhHsp70 alone triggered significant cytokine secretion in concentrations of 0.3, 1 and 3 g ml −1 , and therefore we chose those concentrations for further experiments. Based on the proinflammatory effects of different CSE concentrations (2.5, 5, 10, 15 and 20%), two concentrations of CSE, 2.5 and 15%, were selected for treatments in this study. Both low and high concentration of CSE resulted in increased secretion of measured cytokines, IL-1 , IL-6 and IL-8. In addition, 15% CSE in combination with rhHsp70 showed a pro-inflammatory effect on NCI-H292 cells, as secretion of cytokines was significantly higher compared to the non-treated cells. In contrast, rhHsp70 in combination with 2.5% suppressed the secretion of all three cytokines compared to the 2.5% CSE alone, indicating their antagonistic combined effects.
It was shown previously that eHsp70 could reduce IL-8 secretion from CSE-stimulated lung fibroblasts and 16HBE cells (Dong et al., 2013; Li et al., 2007) ; however, those studies did not use simultaneous application of CSE and rhHsp70 on the cells. Our results also suggest that rhHsp70 may have a protective effect on pro-inflammatory action of CSE in NCI-H292 cells. eHsp70 may activate the immune system cells by binding to TLR2 and TLR4 receptors, which then stimulate MyD88/IRAK/NF-B and MAPK signalling pathways, leading to enhanced synthesis of inflammatory cytokines (Ferat-Osorio et al., 2014; Murshid et al., 2011 ). After we observed changes in cytokine secretion from NCI-H292 cells treated with CSE alone or in combination with rhHsp70, we determined TLR2 and TLR4 mRNA and protein expression as well as expression and phosphorylation of MAPKs and NF-B. We demonstrated that higher concentration of rhHsp70 stimulated TLR2 and TLR4 mRNA compared to non-treated cells, but when applied with 15% CSE it supressed their expression in comparison with CSE alone. In contrast, lower CSE concentration supressed TLR4 mRNA and TLR2 protein expression, with the level of TLR2 being reduced even upon rhHsp70 and 2.5% CSE combined treatments. These results are partly in accordance with results obtained for pro-inflammatory action of CSE on cytokine secretion. CSE alone may act pro-inflammatorily, but addition of rhHsp70 attenuates its pro-inflammatory effects. In the literature, there is not much data on the expression of TLR2 or TLR4 receptor upon treatment of cells with eHsp70. Several studies found that eHsp70 can induce expression of these receptors (Asea et al., 2002; Dybdahl et al., 2005; Vabulas et al., 2002) . On the other hand, there are conflicting reports on how CSE changes TLR2 and TLR4 expressions in different kind of cells. In the alveolar macrophages of patients with COPD and healthy smokers, decreased TLR2 expression was observed (Droemann et al., 2005) , while TLR4 expression in macrophages and monocytes did not vary significantly among the examined groups (Pons et al., 2005 (Pons et al., , 2006 Droemann et al., 2005) .
Metcalfe et al. did not find any difference in gene expression for TLR2 or TLR4 in alveolar macrophages isolated from COPD patients after treatment with CSE (Metcalfe et al., 2014) . It was shown that alterations in TLR4 receptor expression can contribute to the development of emphysema . Also, TLR receptors are involved in exacerbation of COPD and are the primary mediators that activate the immune response to bacteria in the respiratory tract (Doz et al., 2008; Oliveira-Nascimento, Massari, & Wetzler, 2012; Zuo et al., 2015) . Therefore, deregulation of TLR2 and TLR4 receptors by eHsp70 and/or CSE could influence on pathogenesis of COPD. (De Jong, Schadenberg, Jansen, & Prakken, 2009; Giuliano et al., 2011; Krause et al., 2015) . Krause et al. suggested that chronically elevated eHsp70 may result in inflammatory response, inhibition of NF-B and heat shock factor-1 (HSF-1) activation, and reduced intracellular Hsp70 (Krause et al., 2015) . In accordance, in our study addition of low and high concentration of rhHsp70 and higher concentration of CSE significantly reduced expression of intracellular Hsp70 mRNA. However, combinations of 15% CSE and rhHsp70 induced Hsp70 mRNA expression. In the literature, effects of CSE on Hsp70 expression vary depending on the cell type and CSE concentration. Decreased Hsp70 was found in lymphocytes of COPD patients compared to healthy subjects (Zhao, Xie, Xu, Zhang, & Zhang, 2005) , while in pulmonary fibroblasts and 16HBE bronchial epithelial cells Hsp70 was increased (Li et al., 2007) . Rumora et al. investigated the expression of Hsp70 depending on the smoking status, and found its reduced expression in leukocytes of COPD smokers and ex-smokers compared to non-smokers with COPD and in healthy smokers, compared to healthy ex-smokers and non-smokers (Rumora et al., 2008) . The level of Hsp70 was found elevated in lung tissues isolated from COPD patients, and this increase correlated with the severity of the disease (Dong et al., 2013) . Our study suggests that extracellular Hsp70 might have an impact on CSE-provoked effect on intracellular Hsp70 expression, but the underlying mechanism for this phenomenon should be further investigated.
Exposure to cigarette smoke causes activation of MAPK signalling pathways and various transcription factors, such as NF-B and AP-1, in epithelial and endothelial airway cells and in alveolar macrophages (Li et al., 2007; Manzel, Shi, O'Shaughnessy, Thorne, & Look, 2011; Pace et al., 2008; Park, Ryter, Kyung, Lee, & Jeong, 2013) . In our study, we did not detect activation of NF-B. CSE at 15% and its combination with rhHsp70 induced ERK and p38 activation in NCI-H292 cells, whereas lower CSE concentrations alone and applied with rhHsp70 caused ERK phosphorylation. Therefore, it could be concluded that lower CSE concentrations act protectively and activate only the MAPK, which plays a role in cell proliferation (ERK), while higher CSE concentration activates also p38 MAPK, which in general has an apoptotic role; this is consistent with our cell viability data (MTS assay and caspases-3/7 activity). In accordance with this, Luppi et al. showed that CSE activates ERK at low concentrations, while in higher concentrations it activates apoptotic stress kinases p38 and JNK (Luppi et al., 2005) . In this study, no differences were observed between activation of MAPKs in CSEtreated cells compared to cells treated with combinations of CSE with rhHsp70. This may be the result of the western blotting method that we used, as it is generally not sufficiently sensitive to detect minor changes in the activation of the signalling pathways when using a single agent like CSE compared to dual treatments with rhHsp70. Therefore, more sensitive method should be used in future research to determine those differences between individual vs. combined treatments. (Somensi et al., 2017; Zhe et al., 2016) .
In addition to inflammation, cell death is an important factor in the mechanism of the disease development. Activation of TLR2 and TLR4 receptors could also cause programmed cell death (apoptosis), while inflammation can lead to necrosis, which results in release of cellular content and further progression of inflammation (Ofengeim & Yuan, 2013; Vanden Berghe et al., 2014) . Caspases have an important role in apoptosis, which is important for normal functioning of the immune system, and their deregulation is associated with various diseases (Elmore, 2007) . It was reported that low concentrations of CSE caused proliferation, while elevated concentrations and longer exposure time caused apoptosis or significant release of LDH in A549 cells (Kaushik, Kaushik, Khanduja, Pathak, & Khanduja, 2008; Li, Peng, Nie, Shang, & Liu, 2013) . In contrast, Seehasee et al. showed cytotoxicity of lower CSE concentrations on the same cells (Seehase, Baron-Luehr, Kugler, Vollmer, & Goldmann, 2014) . Wu et al. pointed that 2-20% CSE did not cause significant release of LDH into the medium above the lung cells (Wu, Patel, Booth, Zhang, & Metcalf, 2011) . In our study, lower CSE concentrations (2.5%) increased viability of NCI-H292 cells tested by MTS, but also increased LDH release. However, cellular membrane integrity remained intact in cotreatments with rhHsp70. In our previous study we did not detect changes in viability of NCI-H292 cells treated with rhHsp70 alone, and moreover rhHsp70 decreased caspases-3/7 activity (unpublished data). A protective effect of eHsp70 against apoptosis was also shown in a monocyte cell line and Schwann cells (Franco, Terrinca, Rodríguez, Espino, & Pariente, 2016; Luo, Tao, Lin, Mo, & Chen, 2012) . Although rhHsp70 alone has anti-apoptotic effect in NCI-H292 cells, when applied together with CSE it seems that its main effect on cell death shifts toward necrosis. In fact, combinations of rhHsp70 with CSE have a protective effect on plasma membrane integrity. Previous studies showed that the cell death pattern caused by cigarette smoke depends on the cell type, CSE concentration and duration of treatment. CSE in different cell lines (A549, BEAS-2B and Jurkat cells) sometimes caused necrosis and sometimes apoptosis with or without activation of the caspases (Jiao, Ao, Ge, & Xiong, 2008; Kim et al., 2008; Slebos et al., 2007) . It is necessary to take into account the fact that there is no uniformly standardized CSE preparation method, and therefore CSE concentrations of different research teams do not necessarily need to trigger similar inflammatory responses.
In conclusion, we demonstrated that rhHsp70 might modulate the inflammatory response of CSE in NCI-H292 cells on cytokine (IL-1 , IL-6 and IL-8) and mRNA levels (TLR2, TLR4 and Hsp70), and could also act protectively against CSE cytotoxicity. Those effects are exhibited via MAPK and NF-B signalling pathways. The results suggest that extracellular Hsp70 might be implicated in development of inflammatory diseases affected by cigarette smoke, such as COPD.
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